|
Beckman Coulter Genomics Will Use Sanger Technology to Sequence Atlantic Salmon Genome (GenomeWeb News)
Under its new contract with the International Cooperation to Sequence the Atlantic Salmon Genome, Beckman Coulter Genomics will complete the first phase of the project using only Sanger sequencing — the only technology that can currently deliver a reference genome, according to a researcher involved in the project.
(Dec 14, 2009)
BGI-Led Team Publishes Giant Panda Genome Paper (GenomeWeb News)
NEW YORK (GenomeWeb News) – In a paper appearing in the advance, online edition of Nature yesterday, researchers from the Beijing Genomics Institute and elsewhere reported on their sequencing and initial analyses of a draft version of the giant panda genome.
(Dec 14, 2009)
Dyadic Extends Scripps Fungal Genomics Collaboration (GenomeWeb News)
NEW YORK (GenomeWeb News) – Dyadic International has extended a collaboration with The Scripps Research Institute under which Scripps will re-annotate the genome of Dyadic's C1 fungus.
(Dec 14, 2009)
Queensland University of Technology Selects Mitrion Platform to Accelerate Molecular Dynamics, CFD, and Genetic ... (Marketwire)
LUND, SWEDEN--(Marketwire - December 14, 2009) - Mitrionics AB, the technology leader in FPGA-based hybrid computing, today announced that the Queensland University of Technology (QUT) High Performance Computing group has selected the MitrionT Accelerated Computing Platform to explore several projects designed to accelerate algorithms in different application areas. Initial acceleration projects ...
(Dec 14, 2009)
Isis Pharmaceuticals Inc. (ISIS) Director, COO B Lynne Parshall sells 23,000 Shares (Guru Focus)
By insider. Director, COO of Isis Pharmaceuticals Inc. ( ISIS ) B Lynne Parshall sells 23,000 shares of ISIS on 12/11/2009 at an average price of $10.08 a share. Read more » »
(Dec 15, 2009)
Isis Pharmaceuticals Inc. (ISIS) Chairman, President, CEO Stanley T Crooke sells 70,000 Shares (Guru Focus)
By insider. Chairman, President, CEO of Isis Pharmaceuticals Inc. ( ISIS ) Stanley T Crooke sells 70,000 shares of ISIS on 12/14/2009 at an average price of $10.02 a share. Read more » »
(Dec 15, 2009)
India Says It Has Joined Personal Genome Sequencing Club (Bio-IT World)
Times of India | In a press conference last week, Indian scientists led by Sridhar Sivasubbu of the Institute of Genomics and Integrative Biology announced the first whole genome sequencing of an Indian man for an estimated $30,000.
(Dec 15, 2009)
ALS TDI and Applied Proteomics join to identify protein biomarkers associated with ALS (News-Medical-Net)
The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
(Dec 15, 2009)
News Search: (Cambridge Evening News)
Paul's working day is normally on the road, but his "road" is often the Far East. He is the joint CEO of Synoptics and the sales director for Syngene, the world leader in gel documentation and analysis systems, automatic analysers for fluorescence, chemiluminescence and proteomics applications, based in Nuffield Road, Cambridge.
(Dec 15, 2009)
UCLA Researchers Engineer Bacteria To Turn Carbon Dioxide Into Liquid Fuel (PollutionOnline)
Global climate change has prompted efforts to drastically reduce emissions of carbon dioxide, a greenhouse gas produced by burning fossil fuels.
(Dec 15, 2009)
New technique may help diagnose treatments for Alzheimer's, diabetes and cancer (News-Medical-Net)
Chemists and biologists from the University of Bath have developed a new technique that could be used to diagnose and develop treatments for age-related conditions like Alzheimer's disease, diabetes and cancer.
(Dec 15, 2009)
Pandas' bamboo love may be in their genes (The Washington Times)
BEIJING | Genome mapping showing that pandas may prefer a bamboo-based diet because they can't taste meat could unlock secrets to ensuring the survival of the endangered species. The findings published in "Nature" magazine come from a study led by the Beijing Genomics Institute's branch in Shenzhen in southern China. The study found that pandas likely roamed the Earth as far back as 3 million ...
(Dec 15, 2009)
imaGenes GmbH Joins Roche NimbleGen's Certified Service Provider Program for ChIP-chip Analysis (Business Wire via Yahoo! Finance)
MADISON, Wis.----Roche NimbleGen has announced that imaGenes GmbH, a Berlin-based genomics & proteomics specialist, has achieved status as a Certified Service Provider of NimbleGen microarrays for Chromatin Immunoprecipitation . imaGenes GmbH has passed a rigorous ChIP-chip certification to officially become part of the Roche NimbleGen Certified Service Provider Program.
(Dec 15, 2009)
Tibotec Virco Virology BVBA Acquires LAB TRACKER(TM) HIV Electronic Medical Record Software System from Ground Zero ... (PR Newswire via Yahoo! Finance)
Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER⢠HIV, a customized electronic medical record system, from the company Ground Zero Software. LAB TRACKER⢠HIV is a full-service, scalable software platform designed to meet the complex disease-management needs of health care providers who are treating people living with HIV/AIDS.  It facilitates secure data integration ...
(Dec 15, 2009)
Tibotec Virco Virology BVBA acquires Ground Zero Software's LAB TRACKER HIV EMR system (News-Medical-Net)
Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER(TM) HIV, a customized electronic medical record (EMR) system, from the company Ground Zero Software. LAB TRACKER(TM) HIV is a full-service, scalable software platform designed to meet the complex disease-management needs of health care providers who are treating people living with HIV/AIDS.
(Dec 15, 2009)
Knowledge Computing offers new perspectives in scientific computing (uniprotokolle)
Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) and Jülich Supercomputing Centre (JSC) have used automated annotation software on grid-connected supercomputers to perform powerful queries in more than 50,000 pharmaceutical patents. SANKT AUGUSTIN / JÜLICH.
(Dec 15, 2009)
AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for ... (PR Newswire via Yahoo! Finance)
AstraZeneca and the University of Virginia in Charlottesville, today announced that they have entered into a strategic research collaboration to enhance development of new treatments primarily for coronary artery disease with a secondary focus on peripheral vascular disease .
(Dec 15, 2009)
George Nolen, Recently Retired CEO of Siemens Corporation, Joins InVivo Therapeutics Board of Directors (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass.----InVivo Therapeutics Corporation has added George Nolen, former President and Chief Executive Officer of Siemens Corporation, to its Board of Directors. The Board approved the appointment on Friday, December 11th.
(Dec 15, 2009)
Penn Researchers Find Reproductive Germ Cells Survive And Thrive In Transplants, Even Among Species (Medical News Today)
Reproductive researchers from the University of Pennsylvania and The Children's Hospital of Philadelphia have succeeded in isolating and transplanting pure populations of the immature cells that enable male reproduction in two species - human spermatogonia and mouse gonocytes. These germline stem cells, taken from testis biopsies, demonstrated viability following transplantation to mouse testes ...
(Dec 15, 2009)
Tibotec Virco Virology BVBA Acquires LAB TRACKER(TM) HIV Electronic Medical Record Software System from Ground Zero ... (redOrbit)
BRIDGEWATER, N.J, Dec. 15 /PRNewswire/ -- Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER(TM) HIV, a customized electronic medical record (EMR) system, from the company Ground Zero Software.
(Dec 15, 2009)
ImaGenes to Offer Roche NimbleGen Micorarrays (GenomeWeb News)
NEW YORK (GenomeWeb News) – Genomics services provider ImaGenes has received certification from Roche NimbleGen to offer NimbleGen microarrays for chromatin immunoprecipitation (ChIP-chip) services, Roche NimbleGen said today.
(Dec 15, 2009)
Atheist student groups flower on college campuses (Park Hills Daily Journal)
AMES, Iowa (AP) — The sign sits propped on a wooden chair, inviting all comers: “Ask an Atheist.”
(Dec 15, 2009)
Purdue University's DiaGrid, a Cycle Computing Customer, Honored as One of the Top 100 IT Projects of 2009 by the ... (Marketwire via Yahoo! Finance)
NEW YORK, NY--(Marketwire - 12/15/09) - Cycle Computing , providing proven, secure and flexible high performance computing (HPC) and open source solutions in the cloud, today announced that Purdue University's DiaGrid project was selected by IDG's InfoWorld as one of the top 100 IT projects of 2009 in its InfoWorld 100 Awards. DiaGrid, which utilizes the Condor distributed computing system and ...
(Dec 15, 2009)
Purdue University's DiaGrid, a Cycle Computing Customer, Honored as One of the Top 100 IT Projects of 2009 by the ... (Marketwire)
NEW YORK, NY--(Marketwire - December 15, 2009) - Cycle Computing , providing proven, secure and flexible high performance computing (HPC) and open source solutions in the cloud, today announced that Purdue University's DiaGrid project was selected by IDG's InfoWorld as one of the top 100 IT projects of 2009 in its InfoWorld 100 Awards. DiaGrid, which utilizes the Condor distributed computing ...
(Dec 15, 2009)
Trial Date for Illumina’s IP-Infringement Suit Against Affymetrix Moved to Spring 2011 (GenomeWeb News)
In a Dec. 10 order, Magistrate Judge Stephen Crocker of the US District Court for the Western District of Wisconsin agreed on a new schedule for the case, which would schedule a claim-construction hearing for June 2010 and set pretrial conference and trial dates for March 2011.
(Dec 15, 2009)
Scientists Rediscover Gene Target for Cancer Therapy (PR Newswire via Yahoo! Finance)
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science behind its lead oncology product, Rexin-G, when scientists around the world rediscovered the Cyclin G1 gene to be a major locus of cancer pathogenesis and disease progression, and thus a prime target for anti-cancer therapies.
(Dec 15, 2009)
Funding Update (GenomeWeb News)
NIH Grants in Proteomics, July 23 to Dec. 3, part two of two. Principal Investigator : Mani, Denkanikota R. Organization : Broad Institute Title : A Platform for Pattern-Based Proteomic Biomarker Discovery-R01 Start Date : Sept. 30, 2009 End Date : Sept. 29, 2010 Amount in FY 2009 : $193,330
(Dec 15, 2009)
DNA nanomechanics allows direct digital detection of complementary DNA and microRNA targets (Nature)
Techniques to detect and quantify DNA and RNA molecules in biological samples have had a central role in genomics research. Over the past decade, several techniques have been developed to improve detection performance and reduce the cost of genetic analysis. In particular, significant advances in label-free methods have been reported. Yet detection of DNA molecules at concentrations below the ...
(Dec 15, 2009)
Atheist student groups flower on college campuses (Park Hills Daily Journal)
AMES, Iowa (AP) — The sign sits propped on a wooden chair, inviting all comers: “Ask an Atheist.”
(Dec 15, 2009)
Scientists Rediscover Gene Target For Cancer Therapy (BioresearchOnline)
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science behind its lead oncology product, Rexin-G, when scientists around the world rediscovered the Cyclin G1 gene to be a major locus of cancer pathogenesis and disease progression, and thus a prime target for anti-cancer therapies.
(Dec 15, 2009)
AstraZeneca And The University Of Virginia Sign Strategic Research Collaboration To Develop Novel Treatments For ... (BioresearchOnline)
AstraZeneca (NYSE: AZN ) and the University of Virginia (UVa) in Charlottesville, today announced that they have entered into a strategic research collaboration to enhance development of new treatments primarily for coronary artery disease (CAD) with a secondary focus on peripheral vascular disease (PAD).
(Dec 15, 2009)
An easier way to diagnose appendicitis (News 8 Austin)
Appendicitis is the most common childhood surgical emergency, but the diagnosis can be challenging. More than a third of kids don't get diagnosed soon enough and others get the wrong diagnosis. Now researchers created a simple test that could give families the answers they need.
(Dec 15, 2009)
Reproductive Germ Cells Survive And Thrive In Transplants, Even Among Species (redOrbit)
Reproductive researchers from the University of Pennsylvania and The Children’s Hospital of Philadelphia have succeeded in isolating and transplanting pure populations of the immature cells that enable male reproduction in two species—human spermatogonia and mouse gonocytes.
(Dec 15, 2009)
Reproductive germ cells survive and thrive in transplants, even among species (Science Daily)
Reproductive researchers have succeeded in isolating and transplanting pure populations of the immature cells that enable male reproduction in two species -- humans and mice. The germline stem cells, taken from testis biopsies, demonstrated viability following transplantation to mouse testes, providing hope to prepubescent men risking infertility due to cancer treatment.
(Dec 16, 2009)
OEM Microplate Design & Production (BioresearchOnline)
Specialists in microplate technology - Porvair Sciences Ltd. has announced a 20% growth in its OEM design and manufacture business during 2009. In addition to increased sales of private label deep well, assay and PCR plates to existing customers - Porvair Sciences secured 3 new OEM microplate design and manufacture contracts during the last 12 months.
(Dec 16, 2009)
imaGenes achieves Roche NimbleGen CSP-status for ChIP-chip application (News-Medical-Net)
Roche NimbleGen has announced that imaGenes GmbH, a Berlin-based genomics & proteomics specialist, has achieved status as a Certified Service Provider (CSP) of NimbleGen microarrays for Chromatin Immunoprecipitation (ChIP-chip). imaGenes GmbH has passed a rigorous ChIP-chip certification to officially become part of the Roche NimbleGen Certified Service Provider Program.
(Dec 16, 2009)
Press Release (PharmiWeb)
Roche NimbleGen (Pink Sheets:RHHBY) (SWX:RO) (SWX:ROG) has announced that imaGenes GmbH , a Berlin-based genomics & proteomics specialist, has achieved status as a Certified Service Provider (CSP) of NimbleGen microarrays for Chromatin Immunoprecipitation (ChIP-chip). imaGenes GmbH has passed a rigorous ChIP-chip certification to officially become part of the Roche NimbleGen Certified Service ...
(Dec 16, 2009)
Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union (PR Newswire via Yahoo! Finance)
Eppendorf has initiated an import ban for Nanosphere, Inc.'s Verigene and Verigene SP systems for infringement of European patent EP 1 179 180 B2, titled "Method for the identification and/or the quantification of a target compound".
(Dec 16, 2009)
Bioinformatics Expansion Heralds Further Growth for Almac (Marketwire)
CRAIGAVON, NORTHERN IRELAND--(Marketwire - Dec. 16, 2009) - Almac Diagnostics - a personalized medicine company announced the extension of its Bioinformatics department. Almac has shown significant growth in the last year, with employee numbers growing by 15% in the UK and 10% in the US. For the Diagnostics division, this trend continues through the expansion of the Bioinformatics Department and ...
(Dec 16, 2009)
Almac Diagnostics expands its Bioinformatics department (News-Medical-Net)
Almac has shown significant growth in the last year, with employee numbers growing by 15% in the UK and 10% in the US. For the Diagnostics division, this trend continues through the expansion of the Bioinformatics Department and the subsequent opening of a dedicated bioinformatics facility in Manchester (UK).
(Dec 16, 2009)
Eppendorf initiates import ban against Nanosphere's Verigene and Verigene SP systems (News-Medical-Net)
Eppendorf has initiated an import ban for Nanosphere, Inc.'s Verigene(R) and Verigene(R) SP systems for infringement of European patent EP 1 179 180 B2, titled "Method for the identification and/or the quantification of a target compound". The import ban covers any and all imports of the respective products into any country of the European Union. Customs authorities are required to confiscate ...
(Dec 16, 2009)
CombiMatrix Launches New ElectraSense MicroArray Reader (GlobeNewswire via Yahoo! Finance)
MUKILTEO, Wash. -- CombiMatrix Corporation announced today the launch of its next-generation ElectraSense microarray reader.
(Dec 16, 2009)
Alrowad IT Solutions sponsors conference showcasing leading IT experts worldwide (AME Info)
Leading engineers, scientists, researchers and academics in IT from around the world will come together to share their insights.
(Dec 16, 2009)
New Technique Detects Proteins That Make Us Age (Medical News Today)
Chemists and biologists from the University of Bath have developed a new technique that could be used to diagnose and develop treatments for age-related conditions like Alzheimer's disease, diabetes and cancer. In these diseases, proteins in the body react with sugars in a process called glycation. This modifies the protein's function and can trigger complications such as inflammation and ...
(Dec 16, 2009)
Scientists Rediscover Gene Target For Cancer Therapy (Medical News Today)
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science behind its lead oncology product, Rexin-G, when scientists around the world rediscovered the Cyclin G1 gene to be a major locus of cancer pathogenesis and disease progression, and thus a prime target for anti-cancer therapies...
(Dec 16, 2009)
Atheist student groups flower on college campuses (Park Hills Daily Journal)
AMES, Iowa (AP) — The sign sits propped on a wooden chair, inviting all comers: “Ask an Atheist.”
(Dec 16, 2009)
George Church's Challenge to the Genomics Generation (Bio-IT World)
Newsweek | George Church talks about the history of personal genomics, the benefits of genome mapping, and the responsibiliteis of the first genomic generation.
(Dec 16, 2009)
Copenhagen talks (BBC News)
What are the potential deal-breakers?
(Dec 16, 2009)
Disaster Management: a Complex World Brings New Vulnerabilities (Newswise)
James Martin, who specializes in the study of infrastructure for increased resilience to natural or terrorist activities, advocates community-based leadership to minimize disasters. "Government must coordinate efforts but ... we need the transportation, water, power, and other industries to share the leadership."
(Dec 16, 2009)
Subproteomic Fraction Approach Results in 'Most Comprehensive Quantification' of S. Aureus (GenomeWeb News)
By integrating data from four different subproteome fractions, German and Dutch researchers have created a proteomic map of Staphylococcus aureas that they called the "most comprehensive quantitative study of a bacterial genome" to date.
(Dec 16, 2009)
|
